| |
 |
ARTICLES 
|
|
| All-trans-retinoic acid: what is it good for? |
| RP Warrell, Jr |
|
JCO Nov 1 1992: 1659–1661.
[PDF]
|
 |
| Radiation-associated breast cancer after Hodgkin's disease: risks and screening in perspective |
| CL Shapiro and PM Mauch |
|
JCO Nov 1 1992: 1662–1665.
[PDF]
|
|
|
Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer |
| |
MA Smith, PC Adamson, FM Balis, J Feusner, L Aronson, RF Murphy, ME Horowitz, G Reaman, GD Hammond, and RM Fenton |
| |
JCO Nov 1 1992: 1666–1673.
[Abstract]
[PDF]
|
|
|
Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients |
| |
J Yahalom, JA Petrek, PW Biddinger, S Kessler, DD Dershaw, B McCormick, MP Osborne, DA Kinne, and PP Rosen |
| |
JCO Nov 1 1992: 1674–1681.
[Abstract]
[PDF]
|
|
|
High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma |
| |
HM Lazarus, P Crilley, N Ciobanu, RJ Creger, RM Fox, DC Shina, SI Bulova, R Gucalp, BW Cooper, and D Topolsky |
| |
JCO Nov 1 1992: 1682–1689.
[Abstract]
[PDF]
|
|
|
Autologous versus allogeneic bone marrow transplantation for non- Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data |
| |
R Chopra, AH Goldstone, R Pearce, T Philip, F Petersen, F Appelbaum, E De Vol, and P Ernst |
| |
JCO Nov 1 1992: 1690–1695.
[Abstract]
[PDF]
|
|
|
Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti- CD37 antibody in B-cell lymphoma |
| |
MS Kaminski, LM Fig, KR Zasadny, KF Koral, RB DelRosario, IR Francis, CA Hanson, DP Normolle, E Mudgett, and CP Liu |
| |
JCO Nov 1 1992: 1696–1711.
[Abstract]
[PDF]
|
|
|
Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors |
| |
WH Wilson, V Jain, G Bryant, KH Cowan, C Carter, M Cottler-Fox, B Goldspiel, SM Steinberg, DL Longo, and RE Wittes |
| |
JCO Nov 1 1992: 1712–1722.
[Abstract]
[PDF]
|
|
|
Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia |
| |
RA Clift, CD Buckner, FR Appelbaum, G Schoch, FB Petersen, WI Bensinger, J Sanders, KM Sullivan, R Storb, and J Singer |
| |
JCO Nov 1 1992: 1723–1729.
[Abstract]
[PDF]
|
|
|
Feasibility of using quinine, a potential multidrug resistance- reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia |
| |
E Solary, D Caillot, B Chauffert, RO Casasnovas, M Dumas, M Maynadie, and H Guy |
| |
JCO Nov 1 1992: 1730–1736.
[Abstract]
[PDF]
|
|
|
Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone |
| |
WH Meyer, L Kun, N Marina, P Roberson, D Parham, B Rao, B Fletcher, and CB Pratt |
| |
JCO Nov 1 1992: 1737–1742.
[Abstract]
[PDF]
|
|
|
High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report |
| |
SF Williams, T Gilewski, R Mick, and JD Bitran |
| |
JCO Nov 1 1992: 1743–1747.
[Abstract]
[PDF]
|
|
|
Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma |
| |
AI Einzig, PH Wiernik, J Sasloff, CD Runowicz, and GL Goldberg |
| |
JCO Nov 1 1992: 1748–1753.
[Abstract]
[PDF]
|
|
|
Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer |
| |
GR Hudes, R Greenberg, RL Krigel, S Fox, R Scher, S Litwin, P Watts, L Speicher, K Tew, and R Comis |
| |
JCO Nov 1 1992: 1754–1761.
[Abstract]
[PDF]
|
|
|
Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party |
| |
G Read, SP Stenning, MH Cullen, MC Parkinson, A Horwich, SB Kaye, and PA Cook |
| |
JCO Nov 1 1992: 1762–1768.
[Abstract]
[PDF]
|
|
|
Consolidation hemibody radiotherapy following induction combination chemotherapy in high-tumor-burden multiple myeloma |
| |
MR MacKenzie, H Wold, C George, D Gandara, G Ray, S Schiff, J Shields, R Artim, H Davidson, and F Meyers |
| |
JCO Nov 1 1992: 1769–1774.
[Abstract]
[PDF]
|
|
|
CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer |
| |
N Masuda, M Fukuoka, M Takada, Y Kusunoki, S Negoro, K Matsui, S Kudoh, N Takifuji, K Nakagawa, and S Kishimoto |
| |
JCO Nov 1 1992: 1775–1780.
[Abstract]
[PDF]
|
|
|
Metastatic spinal cord compression secondary to lung cancer |
| |
F Bach, N Agerlin, JB Sorensen, TB Rasmussen, P Dombernowsky, PS Sorensen, and HH Hansen |
| |
JCO Nov 1 1992: 1781–1787.
[Abstract]
[PDF]
|
|
|
Suramin: rapid loading and weekly maintenance regimens for cancer patients |
| |
RE van Rijswijk, AC van Loenen, J Wagstaff, E Meijer, R Lopez, CJ van Groeningen, JJ Heimans, and HM Pinedo |
| |
JCO Nov 1 1992: 1788–1794.
[Abstract]
[PDF]
|
|
|
Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study |
| |
M de Forni, MC Malet-Martino, P Jaillais, RE Shubinski, JM Bachaud, L Lemaire, P Canal, C Chevreau, D Carrie, and P Soulie |
| |
JCO Nov 1 1992: 1795–1801.
[Abstract]
[PDF]
|
|
|
Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy |
| |
MB Atkins, G Vachino, HJ Tilg, DD Karp, NJ Robert, K Kappler, and JW Mier |
| |
JCO Nov 1 1992: 1802–1809.
[Abstract]
[PDF]
|
|
|
Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons |
| |
E Kodish, C Stocking, MJ Ratain, A Kohrman, and M Siegler |
| |
JCO Nov 1 1992: 1810–1816.
[Abstract]
[PDF]
|
|
| HER-2/neu oncoprotein as a prognostic factor in breast cancer |
| S Toikkanen and H Joensuu |
|
JCO Nov 1 1992: 1817a.
[PDF]
|
|
| Host factors in breast cancer recurrence |
| HW Daniell |
|
JCO Nov 1 1992: 1817b–1819.
[PDF]
|
|
| Role of thoracic radiotherapy in limited-stage small-cell lung cancer: quantitative review based on the literature versus meta-analysis based on individual data |
| JP Pignon and R Arriagada |
|
JCO Nov 1 1992: 1819–1820.
[PDF]
|
|
| Cyclophosphamide, cisplatin, and abdominal radiation in advanced ovarian cancer |
| RM Auchter |
|
JCO Nov 1 1992: 1820–1821.
[PDF]
|
|
| Rapid response of B-cell prolymphocytic leukemia to 2- chlorodeoxyadenosine |
| K Barton, RA Larson, S O'Brien, and MJ Ratain |
|
JCO Nov 1 1992: 1821.
[PDF]
|
|
